6 Meridian’s Pediatrix Medical MD Stock Holding History

6 Meridian’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,850	Closed	-$349K	–	489
2019 Q2	$349K	Buy	13,850 +594	+4%	+$16K	0.04%	371
2019 Q1	$360K	Buy	13,256 +2,966	+29%	+$99.5K	0.04%	375
2018 Q4	$340K	Sell	10,290 -238	-2%	-$9.57K	0.04%	356
2018 Q3	$491K	Buy	+10,528	New	+$483K	0.05%	312

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

6 Meridian's MD Position: Q3 2019 in Review

6 Meridian sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 13,850 shares — an estimated $349K sold.

6 Meridian first reported a position in MD in Q3 2018 and held it in 4 quarters. The position peaked at $491K in Q3 2018. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

6 Meridian reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
6 Meridian sold 13,850 Pediatrix Medical shares in Q3 2019, an estimated $349K.
6 Meridian first reported a position in Pediatrix Medical in Q3 2018 and held it in 4 quarters.
6 Meridian's Pediatrix Medical position peaked at $491K in Q3 2018.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on 6 Meridian's 13F filing for Q3 2019, filed 22 Oct 2019.